Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency meets with avian flu vaccine manufacturers 9 Μάρτιος 2006Press releaseMedicines Committee for Orphan Medicinal Products: March 2006 meeting 9 Μάρτιος 2006Press releaseHumanRare diseases European Medicines Agency finalises set of guidelines on similar biological medicines and publishes two more new concept papers 8 Μάρτιος 2006Press releaseBiologicalsRegulatory and procedural guidanceMedicines Alcon Laboratories withdraws its application for RETAANE 2 Μάρτιος 2006Press release European Medicines Agency receives second application for human pandemic influenza vaccine 24 Φεβρουάριος 2006Press releaseMedicines Alcon Laboratories (UK) Ltd withdraws its application to extend the marketing authorisation for Opatanol 23 Φεβρουάριος 2006Press release European Medicines Agency: Committee for Medicinal Products for Human Use 20-23 February 2006 23 Φεβρουάριος 2006Press releaseHumanMedicines Committee for medicinal products for veterinary use: Meeting of 14 to 16 February 2006 17 Φεβρουάριος 2006Press releaseVeterinary Committee for Orphan Medicinal Products: February 2006 meeting 8 Φεβρουάριος 2006Press releaseHumanRare diseases European Medicines Agency is consulting on the reflection paper on the use offluoroquinolones in food-producing animals in the European Union: development of resistance and impact on human and animal health 8 Φεβρουάριος 2006Press releaseMedicines 1 … 333 334 335 336 337 Page 337 of 384 338 339 340 341 … 384
European Medicines Agency meets with avian flu vaccine manufacturers 9 Μάρτιος 2006Press releaseMedicines
Committee for Orphan Medicinal Products: March 2006 meeting 9 Μάρτιος 2006Press releaseHumanRare diseases
European Medicines Agency finalises set of guidelines on similar biological medicines and publishes two more new concept papers 8 Μάρτιος 2006Press releaseBiologicalsRegulatory and procedural guidanceMedicines
European Medicines Agency receives second application for human pandemic influenza vaccine 24 Φεβρουάριος 2006Press releaseMedicines
Alcon Laboratories (UK) Ltd withdraws its application to extend the marketing authorisation for Opatanol 23 Φεβρουάριος 2006Press release
European Medicines Agency: Committee for Medicinal Products for Human Use 20-23 February 2006 23 Φεβρουάριος 2006Press releaseHumanMedicines
Committee for medicinal products for veterinary use: Meeting of 14 to 16 February 2006 17 Φεβρουάριος 2006Press releaseVeterinary
Committee for Orphan Medicinal Products: February 2006 meeting 8 Φεβρουάριος 2006Press releaseHumanRare diseases
European Medicines Agency is consulting on the reflection paper on the use offluoroquinolones in food-producing animals in the European Union: development of resistance and impact on human and animal health 8 Φεβρουάριος 2006Press releaseMedicines